BD symposium at EUROGIN 2026
Accelerating cervical cancer elimination: global strategies, national experiences and emerging evidence.
BD Diagnostic Solutions has joined Waters on February 9th!
Join the BD symposium “Accelerating cervical cancer elimination: global strategies, national experiences and emerging evidence”
EUROGIN 2026 19th March 12:45 – 14:00 Hall B
This session will bring together global and national perspectives on achieving the World Health Organisation (WHO)’s 90/70/90 targets. Experts will share insights from global initiatives and acceleration programmes in low- and middle-income countries (LMICs), highlight screening programme transformations in Poland and Denmark and present emerging evidence on HPV genotype-specific risk and its implications for screening and triage strategies.
Dr Ted Trimble
Senior Advisor, Global HPV and Cervical Cancer, NIH, Baltimore, MD, USA
Global momentum toward 90/70/90: success stories from LMICs
Prof Andrzej Nowakowski
Associate Professor, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Transforming cervical screening in Poland: from cytology to HPV testing and beyond
Dr Maija Vahteristo
Researcher, Finnish Cancer Registry, Helsinki, Finland
HPV genotype-specific risk over time: insights from long-term data and implications for cervical cancer screening
Dr Jesper Bonde
Senior Researcher, Head of Unit, Molecular Pathology Laboratory, Copenhagen Univ. Hospital, Denmark
Data-driven evidence informing evolving guidelines and workflow solutions in Denmark
Spin the wheel and test your knowledge!
The EUROGIN congress is a unique opportunity to meet and discuss with peers and industrial representatives about how cervical cancer screening technologies are evolving.
Visit the BD booth to learn how our advanced solutions for cervical cancer screening can help you to stay ahead of the curve. Play the game and meet our experts. Book an appointment with them now.
Book an appointment with an expert at EUROGIN 2026
